Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2025-12-25 @ 4:48 PM
Study NCT ID:
NCT06815003
Status:
RECRUITING
Last Update Posted:
2025-06-27
First Post:
2025-02-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-18
Start Date Type:
ACTUAL
Primary Completion Date:
2028-10-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-15
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-04
First Submit QC Date:
None
Study First Post Date:
2025-02-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-24
Last Update Post Date:
2025-06-27
Last Update Post Date Type:
ACTUAL